Related Experiment Video
Updated: Jun 6, 2026
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
[Adherence and cognitive performance in schizophrenia]
A Spiekermann1, M Schulz, J Behrens
1Abteilung für Forschung, Qualitätssicherung und Dokumentation, Klinik für Psychiatrie und Psychotherapie Bethel, Bielefeld. alexa_spiekermann@gmx.de
Fortschritte Der Neurologie-Psychiatrie
|November 26, 2010
Summary
Patients with schizophrenia experiencing cognitive deficits often show poor adherence to antipsychotic medications. This review highlights the link between cognitive performance and medication adherence in schizophrenia.
Area of Science:
- Psychiatry
- Neuroscience
- Clinical Psychology
Background:
- Schizophrenia is frequently associated with non-adherence to antipsychotic medications.
- Cognitive deficits are a common characteristic of schizophrenia.
- Understanding the interplay between cognition and adherence is crucial for treatment.
Purpose of the Study:
- To systematically review and synthesize findings on the relationship between cognitive performance and medication adherence in schizophrenia patients.
- To explore potential mechanisms linking cognitive impairments to adherence behaviors.
Main Methods:
- A systematic literature review was conducted.
- Studies examining the impact of cognitive performance on adherence in schizophrenia were analyzed.
Main Results:
- Eighteen studies were included in the analysis.
- A consistent finding across most studies indicates that patients with greater cognitive impairments exhibit lower adherence to antipsychotic medications.
- The review discusses potential causal pathways for this observed relationship.
Conclusions:
- Cognitive performance significantly influences medication adherence in schizophrenia.
- Targeting cognitive deficits may be a viable strategy to improve adherence and treatment outcomes in schizophrenia.
- Further research into causal mechanisms is warranted.
Related Concept Videos
01:30Negative and Cognitive Symptoms of Schizophrenia
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:17Schizophrenia
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.
01:29Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...